239. A Liver-Kidney Conundrum - Hepatorenal Syndrome
Jun 2, 2024
auto_awesome
Dr. Cynthia Tsien, a Transplant Hepatologist, discusses the acute presentation of hepatorenal syndrome, including nomenclature, epidemiology, clinical presentation, investigations, and management. The episode also reviews the utility of terlipressin in treating HRS in patients with decompensated cirrhosis.
Hepatorenal syndrome arises from cirrhosis complications causing renal dysfunction due to vasodilation triggers.
Diagnosis and management of HRS require careful assessment, ruling out other causes, involving specialists, and considering liver transplantation.
Deep dives
The Physiology of Hepatorenal Syndrome
Hepatorenal syndrome is a deadly consequence of ascites and decompensated cirrhosis which leads to renal dysfunction. In cirrhosis, portal hypertension triggers vasodilator release, causing fluid retention and decrease in circulating volume, activating the RAS system and resulting in renal vasoconstriction. This delicate balance can be disrupted by triggers like infections or large volume paracentesis, leading to severe AKI.
Diagnosis and Workup of Hepatorenal Syndrome
Diagnosis of HRS involves an increase in creatinine, cirrhosis with ascites, and lack of response to albumin. The new IAC criteria divide type 1 HRS into HRS-AKI and HRS-CKD. Diagnosis requires ruling out other causes of AKI and careful assessment of baseline kidney and liver functions. Assessment includes history taking, physical exam, and a broad renal workup to differentiate HRS from conditions like ATN.
Management Strategies for Hepatorenal Syndrome
The management of HRS involves early recognition, involvement of specialists, and consideration of liver transplantation as the definitive treatment. Initial steps include discontinuing diuretics, empiric antibiotics if infection is suspected, and a fluid challenge with albumin to increase circulating volume. Vasoconstrictors like Minidrine and norepinephrine are used in conjunction with albumin for stage 1B AKI. Renal replacement therapy and potential dialysis may be needed if pharmacologic therapies are ineffective.
1.
Understanding Hepatorenal Syndrome in Patients with Decompensated Cirrhosis
In this episode, we review the acute presentation of hepatorenal syndrome. We review the nomenclature, epidemiology, clinical presentation, investigations and management of hepatorenal syndrome. Our medicine minute reviews the utility of terlipressin in treatment of HRS.
Written by: Dr. Elias Hazan (Internal Medicine Resident) Reviewed by: Dr. Cynthia Tsien (Transplant Hepatologist) and Rupal Shah (General Internal Medicine) Sound Editing by: Tony Walsh